Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycaemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise
Serious Warnings According to safety information on the Direct Meds website, GLP-1 medications "may have serious side effects, including possible thyroid tumors
Overall, clinical evidence supports its potential as a controlled research peptide for metabolic health studies, not as a therapeutic agent
The decision to start Semaglutide GLP-1 therapy should be based on a personalized evaluation of each clients health, discussing potential risks and benefits
Current pricing structure Direct Meds offers several pricing tiers depending on the medication format and commitment length
US$ 27.74
US$ 22.28
US$ 20.91
US$ 20.17
